MRSN

Mersana Therapeutics (MRSN)

Mersana Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MRSN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/17	21 : 26	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/10	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/10	06 : 06	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/09	22 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/09	20 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/09	19 : 59	GlobeNewswire Inc.	Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/04	05 : 30	GlobeNewswire Inc.	Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/05/02	21 : 00	GlobeNewswire Inc.	Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/04/05	05 : 30	GlobeNewswire Inc.	Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/29	06 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/29	06 : 07	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/29	06 : 05	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/28	22 : 49	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/28	22 : 43	Edgar (US Regulatory)	Form POSASR - Post-effective Amendment to an automatic shelf registration statement	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/28	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/28	21 : 00	GlobeNewswire Inc.	Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/27	22 : 01	GlobeNewswire Inc.	Mersana Therapeutics to Present at Upcoming Investor Conferences	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/21	22 : 00	GlobeNewswire Inc.	Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/17	06 : 30	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/15	10 : 56	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/15	10 : 43	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/14	23 : 20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/02/01	22 : 00	GlobeNewswire Inc.	Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc
2024/01/18	07 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRSN	Mersana Therapeutics Inc